Rivaroxaban News and Research

RSS
SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Trial tests effectiveness of two prospective stroke therapies over standard of care

Trial tests effectiveness of two prospective stroke therapies over standard of care

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Study shows adverse outcomes associated with use of more blood thinners

Study shows adverse outcomes associated with use of more blood thinners

Dual-pathway approach can lead to better outcomes in patients with heart stents

Dual-pathway approach can lead to better outcomes in patients with heart stents

Study provides indications and techniques of lower extremity revascularization

Study provides indications and techniques of lower extremity revascularization

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

New research provides welcomed news for countless patients taking PPIs

New research provides welcomed news for countless patients taking PPIs

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

Drug that reverses blood thinning effects stops acute life-threatening bleeding

Drug that reverses blood thinning effects stops acute life-threatening bleeding

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk